OncoDecipher

growth-positive

Groundbreaking research from Tel Aviv University has shown that silent mutations in cancer genomes can predict the type of cancer and the patients survival probability. The study analyzed three million mutations from cancer genomes of 9,915 patients and found that silent mutations can be as predictive as non-silent mutations. By combining information from silent and non-silent mutations, classification and survival estimations could be improved for 68% of cancer types. The study used public genetic information from the National Institute of Health and employed machine learning techniques. The implications of the research will be used in various areas of oncological research.

Not applicable

The article discusses the importance of including silent mutations in cancer research for a broader understanding of the genomic landscape associated with cancer development and progression. The study explores silent and non-silent mutations, aiming to quantify the predictive ability of various types of silent mutations to perform cancer diagnosis and to estimate patients’ survival probabilities over time. The results show that silent mutations do affect cancer mechanisms and hold additional predictive information that could not be obtained from non-silent mutations alone.